Table 2.
Thrombin as a therapeutic target in OA.
| Drug | Target | Reference | |
|---|---|---|---|
| Thrombin antagonists | Vorapaxar (SCH530348) | PAR1 antagonist | [81, 82] |
| Atopaxar (E5555) | PAR1 antagonist | [81, 82] | |
| Hirudin | Cleave fibrinogen and PAR-1 | [74, 83–85] | |
|
| |||
| Herbal medicines | Curcuminoids | Anti-inflammatory | [88, 89] |
| Chondrocytes protection | [88] | ||
| β-Ecdysterone (Ecd) | Bax and p53 reduction | [90] | |
| Increase Bcl-xL expression, | [90] | ||
| Inhibited NF-κB phosphorylation, | [90] | ||
| IκBα degradation, MMP-3, | [90] | ||
| MMP-9, and COX-2 expression | [90] | ||
| Ceiba pentandra (Malvaceae/Bombacoideae) | Coagulation intrinsic pathway | [91] | |
| Prolong clotting time | [91] | ||
| Quassia africana (Simaroubaceae/C. pentandra) | Coagulation intrinsic pathway | [91] | |
| Prolong clotting time | [91] | ||